BC
Biomark Capital Management Co. LLC
Concentrated strategyQuality / disciplined sizing
Total reported value
$8.9M
Reporting period: 2018-09-30 · Number of holdings: 2
Biomark Capital Management Co. LLC disclosed 2 holdings in its latest 13F filing for the period ending 2018-09-30, with total reported value of $8.9M and a quarterly turnover rate of 31.8%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 31.75
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 4
- Sizing Uniformity
- 85.87
Recent moves
Add ADMA
0.0% $2.4M
Trim MBVXEUR
0.0% -$4.0K
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ADMA | Adma Biologics INC | Stock-Healthcare | 99.96% | +0.08% | — | |
| 2 | MBVXEUR | Mabvax Therapeutics Holdings | Stock-Other | 0.04% | -0.08% | — |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2018-09-30 | 2 | $8.9M | 32 | |
| 2018-06-30 | 2 | $6.5M | 2 | |
| 2018-03-31 | 2 | $6.6M | 100 | |
| 2017-12-31 | 3 | $89.8M | 2 | |
| 2017-09-30 | 3 | $88.1M | 39 | |
| 2017-06-30 | 3 | $61.1M | 16 | |
| 2017-03-31 | 3 | $55.2M | 15 | |
| 2016-12-31 | 3 | $48.3M | 44 | |
| 2016-09-30 | 3 | $75.6M | 6 | |
| 2016-06-30 | 3 | $77.9M | 13 | |
| 2016-03-31 | 3 | $72.8M | 12 | |
| 2015-12-31 | 3 | $82.2M | 0 |
Holding changes this quarter
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ADMA | Adma Biologics INC | +0.1% | — | Unchanged |
| 2 | MBVXEUR | Mabvax Therapeutics Holdings | -0.1% | — | Unchanged |
FAQ
What is Biomark Capital Management Co. LLC and what type of investor is it?
Biomark Capital Management Co. LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2018-09-30), the firm manages a tracked equity portfolio valued at approximately $8.9M, spread across 2 disclosed positions.
What are Biomark Capital Management Co. LLC's largest equity positions?
Based on the latest 13F filing, Biomark Capital Management Co. LLC's top holdings by market value are:
1. Adma Biologics INC (ADMA) — $8.9M (100.0%)
2. Mabvax Therapeutics Holdings (MBVXEUR) — $4.0K (0.0%)
What changes did Biomark Capital Management Co. LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Biomark Capital Management Co. LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Biomark Capital Management Co. LLC focus on?
Biomark Capital Management Co. LLC is concentrated in the following sectors based on its current disclosed equity portfolio:
• Health Care: 100.0%